Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

Anesthesiology. 2020 Aug;133(2):430-438. doi: 10.1097/ALN.0000000000003237.

Authors

Jean-Charles Preiser¹, Bruna Provenzano, Wasineeart Mongkolpun, Katarina Halenarova, Miriam Cnop

Affiliation

¹ From the Departments of Intensive Care (J.-C.P., B.P., W.M., K.H.) Anesthesiology (K.H.) Erasmus Hospital, the Division of Endocrinology (M.C.) the Center for Diabetes Research (M.C.), Free University of Brussels, Brussels, Belgium.

PMID: 32667156
DOI: 10.1097/ALN.0000000000003237

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Administration, Oral
Biguanides / administration & dosage
Blood Glucose / drug effects*
Blood Glucose / metabolism
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / surgery
Dipeptidyl-Peptidase IV Inhibitors / administration & dosage
Humans
Hypoglycemic Agents / administration & dosage*
Perioperative Care / methods*
Perioperative Care / trends

Substances

Biguanides
Blood Glucose
Dipeptidyl-Peptidase IV Inhibitors
Hypoglycemic Agents